Alkermes said patients testing its schizophrenia treatment showed significantly less weight gain on average than those using an established antipsychotic drug.
from WSJ.com: US Business http://ift.tt/1IrpIkc
via IFTTT
from WSJ.com: US Business http://ift.tt/1IrpIkc
via IFTTT
No comments:
Post a Comment